Economic impact of switching from partially combined vaccine “Pentaxim® and hepatitis B” to fully combined vaccine “Hexaxim®” in the Malaysian National Immunization Program

Posted on by

BMC Health Services Research
http://www.biomedcentral.com/bmchealthservres/content
(Accessed 08 Jan 2022)

 

Economic impact of switching from partially combined vaccine “Pentaxim® and hepatitis B” to fully combined vaccine “Hexaxim®” in the Malaysian National Immunization Program
The decision to implement new vaccines should be supported by public health and economic evaluations. Therefore, this study was primarily designed to evaluate the economic impact of switching from partially co…
Authors: Syed Mohamed Aljunid, Lama Al Bashir, Aniza Binti Ismail, Azimatun Noor Aizuddin, S. A. Zafirah Abdul Rashid and Amrizal Muhammad Nur
Citation: BMC Health Services Research 2022 22:34
Content type: Research
Published on: 5 January 2022